... a $1.7 billion charge for the April 1 acquisition of Pandion Therapeutics, a biotech company developing new treatments for autoimmune diseases.
News
- Merck weighed down by charges in Q2, but drug sales rebound
- Genocea Biosciences: Q2 Earnings Snapshot
(AP) _ Genocea Biosciences Inc. (GNCA) on Thursday reported a loss of $4.3 million in its second quarter. On a per-share basis, the Cambridge, ...
- IGM Biosciences Announces the Appointment of Chris H. Takimoto, MD, Ph.D., FACP, as Chief ...
He has over thirty years of experience in industry and academia, including academic positions at the University of Texas Health Science Center at San ...
- San Antonio Street Performer Arrested For Dancing Fights Back
Valadez' attorney is claiming that the San Antonio Police Department's ... Oklahoma City is known for lucrative industries such as aviation, biotech, ...
- Vice Dean for Research & Scholarship, School of Nursing
The School of Nursing at UT Health San Antonio is delighted to invite ... of the PhD Program alongside the Graduate School of Biomedical Sciences.